Variant report

Variant	esv3412213
Chromosome Location	chr9:96716656-96718704
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:50)
CpG islands
(count:305)
Chromatin interactive
region (count:3)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:50 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CCNT2	chr9:96716766-96716864	K562	blood:	n/a	n/a
2	CHD1	chr9:96716565-96716690	H1-hESC	embryonic stem cell:	n/a	n/a
3	CHD1	chr9:96717050-96717171	H1-hESC	embryonic stem cell:	n/a	n/a
4	CREB1	chr9:96717701-96718246	H1-hESC	embryonic stem cell:	n/a	n/a
5	CREB1	chr9:96717840-96718132	A549	lung:	n/a	n/a
6	CTBP2	chr9:96710652-96717425	H1-hESC	embryonic stem cell:	n/a	n/a
7	CTBP2	chr9:96717720-96718392	H1-hESC	embryonic stem cell:	n/a	n/a
8	E2F6	chr9:96716852-96717262	H1-hESC	embryonic stem cell:	n/a	chr9:96717156-96717171 chr9:96717160-96717172
9	E2F6	chr9:96716184-96717258	H1-hESC	embryonic stem cell:	n/a	chr9:96717156-96717171 chr9:96716525-96716533 chr9:96716525-96716533 chr9:96716808-96716818 chr9:96717160-96717172 chr9:96716526-96716533 chr9:96716848-96716858 chr9:96716519-96716529 chr9:96716524-96716534
10	E2F6	chr9:96717588-96718179	A549	lung:	n/a	n/a
11	E2F6	chr9:96717620-96718035	A549	lung:	n/a	n/a
12	GABPA	chr9:96716515-96716984	H1-hESC	embryonic stem cell:	n/a	n/a
13	GABPA	chr9:96716584-96717152	H1-hESC	embryonic stem cell:	n/a	n/a
14	JUND	chr9:96717943-96718121	H1-hESC	embryonic stem cell:	n/a	n/a
15	MAX	chr9:96717597-96718204	H1-hESC	embryonic stem cell:	n/a	chr9:96718083-96718093 chr9:96717947-96717956
16	MAX	chr9:96717738-96718009	H1-hESC	embryonic stem cell:	n/a	chr9:96717947-96717956
17	MAX	chr9:96716412-96717217	H1-hESC	embryonic stem cell:	n/a	n/a
18	MAX	chr9:96716327-96717225	H1-hESC	embryonic stem cell:	n/a	n/a
19	MAX	chr9:96717625-96718311	ECC-1	luminal epithelium:	n/a	chr9:96718083-96718093 chr9:96717947-96717956
20	MAX	chr9:96717509-96718383	A549	lung:	n/a	chr9:96718083-96718093 chr9:96717947-96717956
21	MAX	chr9:96717769-96718089	A549	lung:	n/a	chr9:96717947-96717956
22	MAX	chr9:96717543-96718283	ECC-1	luminal epithelium:	n/a	chr9:96718083-96718093 chr9:96717947-96717956
23	MAX	chr9:96717691-96718261	A549	lung:	n/a	chr9:96718083-96718093 chr9:96717947-96717956
24	MAX	chr9:96716821-96717314	A549	lung:	n/a	n/a
25	MYC	chr9:96718258-96718312	MCF-7	breast:	n/a	n/a
26	NFIC	chr9:96717683-96718044	ECC-1	luminal epithelium:	n/a	n/a
27	POLR2A	chr9:96717698-96718084	PANC-1	pancreas:	n/a	n/a
28	POLR2A	chr9:96717708-96717880	A549	lung:	n/a	n/a
29	POLR2A	chr9:96715218-96716678	H1-neurons	neurons:	n/a	n/a
30	POLR2A	chr9:96717784-96718023	A549	lung:	n/a	n/a
31	POLR2A	chr9:96716169-96718368	Hela-S3	cervix:	n/a	n/a
32	POLR2A	chr9:96717704-96717965	ECC-1	luminal epithelium:	n/a	n/a
33	POLR2A	chr9:96717716-96718108	PANC-1	pancreas:	n/a	n/a
34	POLR2A	chr9:96717764-96717894	Hela-S3	cervix:	n/a	n/a
35	POLR2A	chr9:96717765-96718115	H1-neurons	neurons:	n/a	n/a
36	POLR2A	chr9:96717779-96718291	H1-neurons	neurons:	n/a	n/a
37	POLR2A	chr9:96717488-96717998	A549	lung:	n/a	n/a
38	POLR2A	chr9:96717718-96718119	ECC-1	luminal epithelium:	n/a	n/a
39	POLR2A	chr9:96717435-96718196	HEK293	kidney:	n/a	n/a
40	REST	chr9:96717766-96717935	A549	lung:	n/a	n/a
41	SIN3A	chr9:96717750-96718284	H1-hESC	embryonic stem cell:	n/a	chr9:96717791-96717800
42	SIN3A	chr9:96716966-96717048	H1-hESC	embryonic stem cell:	n/a	n/a
43	SUZ12	chr9:96717789-96718414	H1-hESC	embryonic stem cell:	n/a	n/a
44	SUZ12	chr9:96709708-96717433	H1-hESC	embryonic stem cell:	n/a	n/a
45	TCF7L2	chr9:96717737-96718216	PANC-1	pancreas:	n/a	n/a
46	USF1	chr9:96717697-96718011	ECC-1	luminal epithelium:	n/a	n/a
47	ZBTB7A	chr9:96717542-96718338	ECC-1	luminal epithelium:	n/a	chr9:96717635-96717644
48	ZBTB7A	chr9:96717532-96718337	ECC-1	luminal epithelium:	n/a	chr9:96717635-96717644
49	ZNF143	chr9:96717758-96718085	H1-hESC	embryonic stem cell:	n/a	n/a
50	ZNF143	chr9:96716819-96716827	H1-hESC	embryonic stem cell:	n/a	n/a

(count:305 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:96718643-96718693	HEEpiC	esophagus:	n/a
2	chr9:96716928-96716978	BJ	skin:	n/a
3	chr9:96716665-96716715	K562	blood:	n/a
4	chr9:96717349-96717399	HCM	heart:	n/a
5	chr9:96717349-96717399	GM12891	blood:	n/a
6	chr9:96716998-96717048	IMR90	lung:	fetal
7	chr9:96716998-96717048	HCF	heart:	n/a
8	chr9:96718643-96718693	HCT-116	colon:	n/a
9	chr9:96716998-96717048	SAEC	small airway:	n/a
10	chr9:96718643-96718693	NHBE	bronchial:	n/a
11	chr9:96716928-96716978	AG10803	skin:	n/a
12	chr9:96716998-96717048	SK-N-MC	brain:	n/a
13	chr9:96716665-96716715	A549	lung:	n/a
14	chr9:96716998-96717048	CMK	blood:	n/a
15	chr9:96716665-96716715	SK-N-SH	brain:	n/a
16	chr9:96718643-96718693	HRCEpiC	kidney:	n/a
17	chr9:96717349-96717399	GM12878	blood:	n/a
18	chr9:96716928-96716978	HepG2	liver:	n/a
19	chr9:96716998-96717048	AG04449	skin:	fetal
20	chr9:96716665-96716715	NHBE	bronchial:	n/a
21	chr9:96717349-96717399	NHDF-neo	bronchial:	n/a
22	chr9:96716998-96717048	AG09319	gingival:	n/a
23	chr9:96716665-96716715	HepG2	liver:	n/a
24	chr9:96718643-96718693	SKMC	muscle:	n/a
25	chr9:96718643-96718693	PANC-1	pancreas:	n/a
26	chr9:96717349-96717399	MCF-7	breast:	n/a
27	chr9:96716998-96717048	LNCaP	prostate:	n/a
28	chr9:96718643-96718693	AG04450	lung:	fetal
29	chr9:96716665-96716715	HCF	heart:	n/a
30	chr9:96716998-96717048	GM06990	blood:	n/a
31	chr9:96717349-96717399	CMK	blood:	n/a
32	chr9:96717349-96717399	ECC-1	luminal epithelium:	n/a
33	chr9:96716665-96716715	GM12878	blood:	n/a
34	chr9:96716665-96716715	NT2-D1	testis:	n/a
35	chr9:96716998-96717048	HMEC	breast:	n/a
36	chr9:96716928-96716978	HL-60	blood:	n/a
37	chr9:96718643-96718693	HUVEC	blood vessel:	n/a
38	chr9:96717349-96717399	K562	blood:	n/a
39	chr9:96716998-96717048	GM19239	blood:	n/a
40	chr9:96718643-96718693	HPAEpiC	pulmonary alveolar:	n/a
41	chr9:96716928-96716978	NT2-D1	testis:	n/a
42	chr9:96716998-96717048	HepG2	liver:	n/a
43	chr9:96716928-96716978	LNCaP	prostate:	n/a
44	chr9:96716665-96716715	HCT-116	colon:	n/a
45	chr9:96718643-96718693	RPTEC	kidney:	n/a
46	chr9:96718643-96718693	SK-N-SH	brain:	n/a
47	chr9:96717349-96717399	HepG2	liver:	n/a
48	chr9:96716928-96716978	AG09319	gingival:	n/a
49	chr9:96716665-96716715	AG10803	skin:	n/a
50	chr9:96716928-96716978	PrEC	prostate:	n/a

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr9:96718522..96721455-chr9:96725392..96727968,2	MCF-7	breast:
2	chr9:96713619..96716485-chr9:96717370..96719166,2	K562	blood:
3	chr9:96709646..96715968-chr9:96715980..96721050,10	MCF-7	breast:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-PTPDC1-1	chr9:96718116-96719150	XLOC_007466
2	lnc-PTPDC1-1	chr9:96717879-96717922	XLOC_007466

No data

Variant related genes	Relation type
ENSG00000235601	TF binding region
BARX1	TF binding region
ENSG00000235601	CpG island
BARX1	CpG island
ENSG00000131668	chromatin interactions
BCL2L11	miRNA target sites

Extended variants
information (count: 45 )
Associated
traits (count: 73 )

Variant overlapped rSNPs/rCNVs (count:45 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs559897600	chr9:96716699-96716700	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
2	rs538945515	chr9:96716842-96716843	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers Weak transcription Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
3	rs184215939	chr9:96716860-96716861	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers Weak transcription Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
4	rs566237320	chr9:96716955-96716956	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers Weak transcription Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
5	rs536462529	chr9:96716978-96716979	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers Weak transcription Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
6	rs187083011	chr9:96716984-96716985	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers Weak transcription Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
7	rs369765897	chr9:96716992-96716993	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers Weak transcription Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
8	rs576160166	chr9:96716996-96716997	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers Weak transcription Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
9	rs537046829	chr9:96717050-96717051	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
10	rs367791188	chr9:96717160-96717161	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
11	rs578112281	chr9:96717162-96717163	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
12	rs576837358	chr9:96717278-96717279	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
13	rs191789925	chr9:96717287-96717288	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs560200241	chr9:96717299-96717300	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
15	rs572186737	chr9:96717417-96717418	Bivalent/Poised TSS Bivalent Enhancer Active TSS Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
16	rs386736405	chr9:96717778-96717779	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
17	rs542482502	chr9:96717831-96717832	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
18	rs560961160	chr9:96717842-96717843	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
19	rs183910969	chr9:96717875-96717876	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
20	rs531474182	chr9:96717903-96717904	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
21	rs141801279	chr9:96717936-96717937	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
22	rs564821491	chr9:96717937-96717938	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
23	rs532034273	chr9:96717952-96717953	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs548035938	chr9:96717980-96717981	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
25	rs566279741	chr9:96718002-96718003	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
26	rs189606437	chr9:96718016-96718017	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
27	rs548423614	chr9:96718085-96718086	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
28	rs147216906	chr9:96718142-96718143	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
29	rs200886371	chr9:96718161-96718162	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
30	rs537108699	chr9:96718216-96718217	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
31	rs558647008	chr9:96718223-96718224	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
32	rs570789323	chr9:96718262-96718263	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
33	rs534740078	chr9:96718288-96718289	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
34	rs142672979	chr9:96718314-96718315	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
35	rs572297354	chr9:96718348-96718349	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
36	rs542797419	chr9:96718383-96718384	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
37	rs375868299	chr9:96718414-96718415	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
38	rs554763913	chr9:96718416-96718417	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
39	rs374102534	chr9:96718425-96718426	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
40	rs112598128	chr9:96718475-96718476	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
41	rs576305462	chr9:96718508-96718509	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
42	rs147381780	chr9:96718551-96718552	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
43	rs564989933	chr9:96718562-96718563	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
44	rs4563951	chr9:96718590-96718591	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs540697936	chr9:96718680-96718681	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription	CpG island Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:73)

Disease	PMID	Source
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Medulloblastoma	21979893	CNVD
microdeletion syndrome	16199537	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Cancer	20164919	CNVD
Urothelial carcinoma	21177765	CNVD
Renal cell carcinoma	21668985	CNVD
Autism	22495311	CNVD
Melanoma	18172304	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	16751803	CNVD
Myelofibrosis	22110671	CNVD
lymphocytic leukemia	21291569	CNVD
Leukemia	17361228	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Glioblastoma	16823260	CNVD
Leukemia	18688285	CNVD
Non-small cell lung cancer	21044232	CNVD
Brain cancer	20823417	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Astrocytoma	17387387	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Renal cell carcinoma	19461508	CNVD
Neuroblastoma	18923191	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Heart disease	21282601	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Lung cancer	18438408	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute myeloid leukemia	21251322	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	17603634	CNVD
Acute myeloid leukemia	20729466	CNVD
Oral cancer	21386901	CNVD
Bipolar disorder	18458673	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Wilms tumour	21544195	CNVD
Prostate cancer	18632612	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Gastric cancer	17908304	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Biliary cancer	19435499	CNVD
small cell lung cancer	20016488	CNVD
Intracranial aneurysm	16715129	CNVD
Cardiac fibroma	18329553	CNVD
Mental retardation	21693067	CNVD
Breast cancer	17133270	CNVD
Basal cell nevus syndrome	21572526	CNVD
Mental retardation	19951919	CNVD
Retinoblastoma	22278416	CNVD
9q22.3 microdeletion syndrome	22283845	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Microcephaly	18830227	CNVD
overgrowth syndrome	16570072	CNVD
Breast cancer	22522925	CNVD
Effusion lymphoma	18079361	CNVD

Chromatin state (count:342 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:96713000-96717000	Transcr. at gene 5' and 3'	Stomach Smooth Muscle	stomach
2	chr9:96713800-96716800	Bivalent Enhancer	Brain Germinal Matrix	brain
3	chr9:96713800-96716800	Bivalent Enhancer	Brain Substantia Nigra	brain
4	chr9:96713800-96717000	Bivalent Enhancer	Fetal Muscle Trunk	muscle
5	chr9:96713800-96717200	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
6	chr9:96713800-96717400	Bivalent Enhancer	Fetal Muscle Leg	muscle
7	chr9:96713800-96717800	Bivalent Enhancer	Liver	Liver
8	chr9:96713800-96718400	Bivalent Enhancer	Lung	lung
9	chr9:96714200-96717200	Bivalent Enhancer	Primary B cells from peripheral blood	blood
10	chr9:96714200-96717400	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
11	chr9:96714200-96717800	Enhancers	Pancreas	Pancrea
12	chr9:96714400-96717000	Bivalent Enhancer	Adipose Nuclei	Adipose
13	chr9:96714400-96717200	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
14	chr9:96714600-96716800	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
15	chr9:96714600-96716800	Bivalent Enhancer	Duodenum Smooth Muscle	Duodenum
16	chr9:96714600-96717000	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
17	chr9:96714600-96717000	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
18	chr9:96714600-96717000	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
19	chr9:96714800-96716800	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
20	chr9:96715000-96717000	Bivalent Enhancer	Primary T helper naive cells from peripheral blood	blood
21	chr9:96715000-96718800	Bivalent Enhancer	Spleen	Spleen
22	chr9:96715400-96716800	Bivalent Enhancer	Primary T helper naive cells fromperipheralblood	blood
23	chr9:96715400-96717200	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
24	chr9:96715800-96717000	Bivalent Enhancer	Brain Hippocampus Middle	brain
25	chr9:96715800-96717000	Weak transcription	Right Atrium	heart
26	chr9:96715800-96717200	Bivalent Enhancer	Primary T cells effector/memory enriched fromperipheralblood	blood
27	chr9:96715800-96717200	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
28	chr9:96716000-96717000	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
29	chr9:96716000-96717000	Bivalent Enhancer	Brain Inferior Temporal Lobe	brain
30	chr9:96716000-96717200	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
31	chr9:96716000-96717400	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
32	chr9:96716200-96718200	Active TSS	Osteobl	bone
33	chr9:96716400-96716800	Bivalent Enhancer	H9 Cell Line	embryonic stem cell
34	chr9:96716400-96716800	Bivalent Enhancer	Primary T helper memory cells from peripheral blood 1	blood
35	chr9:96716400-96716800	Bivalent Enhancer	Fetal Brain Female	brain
36	chr9:96716400-96717000	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
37	chr9:96716400-96717000	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
38	chr9:96716400-96717000	Bivalent Enhancer	Placenta	Placenta
39	chr9:96716400-96717200	Bivalent Enhancer	Placenta Amnion	Placenta Amnion
40	chr9:96716400-96717200	Flanking Bivalent TSS/Enh	Right Ventricle	heart
41	chr9:96716400-96717800	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
42	chr9:96716400-96718400	Active TSS	Hela-S3	cervix
43	chr9:96716400-96718600	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
44	chr9:96716400-96718600	Bivalent/Poised TSS	Fetal Stomach	stomach
45	chr9:96716400-96718800	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
46	chr9:96716600-96716800	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
47	chr9:96716600-96716800	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
48	chr9:96716600-96716800	Bivalent Enhancer	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
49	chr9:96716600-96716800	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Male	--
50	chr9:96716600-96716800	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links